GW-9662

• Background:

  Selective PPARγ antagonist (IC50 = 3.3, 32 and 2000 nM for PPARγ, PPARα and PPARδ respectively) 1. Blocks the inhibition of osteoclast formation induced by IL-4 (1-2 μM) 2. Displays anticancer activity inhibits growth of human mammary tumor cell lines3. A useful tool for dissecting the involvement of PPARγ in cellular physiology4,5.

• Conjugation:

  Unconjugated

• Buffer:

  White or off-white solid

• Storage Conditions:

  RT